Synaptogenix Inc (SNPX)

[blu_1]

Why a 3 month Ph 3 trial Antti to prove bryostatin's safety and efficacy in Alzheimers patients? Why not just give one dose, like the joke that was the Ph 2a trial, and then follow up for testing 3 hrs later and call it a day/trial (apparently in the compassionate use patient that's only how long it took for improvement. A "miracle"! to quote Alkon. Case closed, cure found! Lol). Why drag things out for 3 long months? Shareholders should be complaining about unnecessary waste and delay!

According to Antti's logic, Aricept reversed/cured Alzheimers years ago based on its 3 month trial results! Why isn't this news? Some kinda Russian conspiracy? Sorry Neurotrope, Phizer's Aricept beat you to the punch :(

Anavex 273 has posted unprecedented clinical trial results each time its given them over the past two years at major Alzheimers scientific conferences, which is the expected venue to present trial results of a substantive nature. Why? So results and trial design can be subject to peer review and discussion. George Perry, Alzheimers researcher and editor of the Journal of Alzheimers Disease, said last December that 2-73 is the best Alzheimers drug he's seen. Funny he didn't mention bryostatin given that his journal did run an article on it. Smart of Neurotrope to stay away from the scrutiny of the scientists at those conferences when they put out their spin/PR. Keep things on the down low and pray Trump's corporate friendly, soon to be gutted, FDA plays along.

Bryostatin's motto, "If at 1st, 2nd, 17th, 25th, 39th, you don't succeed, try try again!" Lol Sink another $2 million into it, gotta be good for something right? Head lice maybe?